AMBASARABH
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
Ambalal Sarabhai Enterprises Says Telerad Division Of Unit Signs Agreement With Bolin Technology
Nov 20 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - TELERAD DIVISION OF UNIT SIGNS AGREEMENT WITH BOLIN TECHNOLOGY
Further company coverage: AMBL.BO
(([email protected];))
Nov 20 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - TELERAD DIVISION OF UNIT SIGNS AGREEMENT WITH BOLIN TECHNOLOGY
Further company coverage: AMBL.BO
(([email protected];))
Ambalal Sarabhai Enterprises Says CFO Navinchandra Patel Resigns
May 1 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES - CFO NAVINCHANDRA PATEL RESIGNS
Source text for Eikon: ID:nBSE2nDWx6
Further company coverage: AMBL.BO
(([email protected];))
May 1 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES - CFO NAVINCHANDRA PATEL RESIGNS
Source text for Eikon: ID:nBSE2nDWx6
Further company coverage: AMBL.BO
(([email protected];))
Ambalal Sarabhai Enterprises Names Mohal K. Sarabhai As MD
Aug 24 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
NAMES MOHAL K. SARABHAI AS MD
Source text for Eikon: ID:nBSE9thFtH
Further company coverage: AMBL.BO
(([email protected];;))
Aug 24 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
NAMES MOHAL K. SARABHAI AS MD
Source text for Eikon: ID:nBSE9thFtH
Further company coverage: AMBL.BO
(([email protected];;))
Ambalal Sarabhai Enterprises Says Unit Asence Pharma Commences New Oncology And Synthetic API Plant At Ranoli, Vadodara
June 9 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - UNIT ASENCE PHARMA COMMENCES NEW ONCOLOGY AND SYNTHETIC API PLANT AT RANOLI, VADODARA
Source text for Eikon: [ID:]
Further company coverage: AMBL.BO
(([email protected];))
June 9 (Reuters) - Ambalal Sarabhai Enterprises Ltd AMBL.BO:
AMBALAL SARABHAI ENTERPRISES LTD - UNIT ASENCE PHARMA COMMENCES NEW ONCOLOGY AND SYNTHETIC API PLANT AT RANOLI, VADODARA
Source text for Eikon: [ID:]
Further company coverage: AMBL.BO
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Ambalal Sarabhai Ent do?
Established in 1978, Ambalal Sarabhai Enterprises Limited, commonly known as Sarabhai, is a prominent manufacturer in the Indian pharmaceutical industry.
Who are the competitors of Ambalal Sarabhai Ent?
Ambalal Sarabhai Ent major competitors are Balaxi Pharma., Gennex Lab, Kimia Biosciences, Trident Lifeline, Coral Laboratories, Alpa Lab, Murae Organisor. Market Cap of Ambalal Sarabhai Ent is ₹275 Crs. While the median market cap of its peers are ₹225 Crs.
Is Ambalal Sarabhai Ent financially stable compared to its competitors?
Ambalal Sarabhai Ent seems to be less financially stable compared to its competitors. Altman Z score of Ambalal Sarabhai Ent is 2.49 and is ranked 7 out of its 8 competitors.
Does Ambalal Sarabhai Ent pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Ambalal Sarabhai Ent latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Ambalal Sarabhai Ent allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Ambalal Sarabhai Ent balance sheet?
Balance sheet of Ambalal Sarabhai Ent is moderately strong.
Is the profitablity of Ambalal Sarabhai Ent improving?
No, profit is decreasing. The profit of Ambalal Sarabhai Ent is ₹4.29 Crs for TTM, ₹5.68 Crs for Mar 2024 and ₹11.45 Crs for Mar 2023.
Is the debt of Ambalal Sarabhai Ent increasing or decreasing?
Yes, The net debt of Ambalal Sarabhai Ent is increasing. Latest net debt of Ambalal Sarabhai Ent is ₹37.07 Crs as of Mar-25. This is greater than Mar-24 when it was -₹20.67 Crs.
Is Ambalal Sarabhai Ent stock expensive?
Ambalal Sarabhai Ent is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Ambalal Sarabhai Ent is 55.76, while 3 year average PE is 29.84. Also latest EV/EBITDA of Ambalal Sarabhai Ent is 38.62 while 3yr average is 41.06.
Has the share price of Ambalal Sarabhai Ent grown faster than its competition?
Ambalal Sarabhai Ent has given better returns compared to its competitors. Ambalal Sarabhai Ent has grown at ~24.15% over the last 2yrs while peers have grown at a median rate of 24.01%
Is the promoter bullish about Ambalal Sarabhai Ent?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Ambalal Sarabhai Ent is 31.35% and last quarter promoter holding is 31.35%.
Are mutual funds buying/selling Ambalal Sarabhai Ent?
There is Insufficient data to gauge this.